News & Events

Industry News

  • Acelity: Files Registration Statement for Proposed Initial Public Offering
  • 26/08/2015

  •          SAN ANTONIO, August 26, 2015 - Acelity Holdings, Inc. (“Acelity”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Acelity is a wholly-owned subsidiary of Acelity L.P. Inc., and in connection with this offering, Acelity will become the parent company of Acelity L.P. Inc.’s advanced wound care and regenerative medicine businesses.
             J.P. Morgan, Goldman, Sachs & Co. and BofA Merrill Lynch are acting as joint book-running managers for the proposed offering. The offering will be made only by means of a prospectus.

      Company Name ACELITY HOLDINGS, INC.
      Company Address 12390 WEST INTERSTATE 10, SAN ANTONIO, TX 78249
      Company Phone 210-524-9000
      Company Website
      CEO Joseph F. Woody
      Employees (as of 12/31/2014) 5700
      State of Inc TX
      Fiscal Year End 12/31
      Status Filed (8/26/2015)
      Exchange New York Stock Exchange
      Offer Amount $1,000,000,000.00
      Lockup Period (days) 180
      CIK 0001651347

Copyright © 4L Health Co., Ltd. & Foryou Medical Electronics Co., Ltd. All Rights Reserved.